Electromed (ELMD) vs Treace Medical Concepts (TMCI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Electromed (ELMD) has outperformed Treace Medical Concepts (TMCI) over the past year, gaining 14.4% versus a loss of 35.2%. Over five years, ELMD leads with a +156.6% price change compared with -84.1% for TMCI. Treace Medical Concepts is the larger company by market cap ($252.0 million vs $230.4 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ELMD | TMCI |
|---|---|---|
| Share price | $27.80 | $3.88 |
| Market cap | $230.38M | $252.01M |
| 1-day change | -1.42% | -0.39% |
| YTD return | -3.16% | +58.78% |
| 1-year return | +14.45% | -35.17% |
| 5-year return | +156.60% | -84.07% |
| P/E ratio (TTM) | 21.38 | — |
| Forward P/E | 45.57 | — |
| EPS (TTM) | $1.30 | $-0.92 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $47.40 | $7.08 |
| 52-week low | $23.01 | $1.17 |
| Distance from 52-week high | -41.35% | -45.27% |
| Analyst consensus | none | none |
| Avg. price target upside | +74.46% | +41.94% |
| Average volume | 104.76K | 330.27K |
| Shares outstanding | 8.29M | 65.03M |
| Employees | 195 | 450 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ELMD has outperformed TMCI by 49.6 percentage points over the past year.
About Electromed
ELMD stock →Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 195 employees
About Treace Medical Concepts
TMCI stock →Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty System, enables surgeons to correct all three dimensions of the bunion deformity, stabilize the first TMT joint, and allow return to weight-bearing in a walking boot; minimally invasive products for four bunion classes; Nanoplasty 3D Minimally Invasive Bunion Correction System delivers a reproducible 3D correction of the bunion deformity through a cosmetically appealing; and Percuplasty Percutaneous 3D Bunion Correction System that provides 3D correction of the bunion deformity through percutaneous incisions.
Health Care · Medical/Dental Instruments · 450 employees
ELMD vs TMCI FAQ
Which is bigger, Electromed or Treace Medical Concepts?
Treace Medical Concepts (TMCI) is larger, with a market capitalization of $252.01M compared with $230.38M for Electromed (ELMD).
Which stock has performed better over the past year, ELMD or TMCI?
ELMD returned +14.45% over the past 12 months, compared with -35.17% for TMCI (price return, excluding dividends). Past performance does not predict future results.
Are Electromed and Treace Medical Concepts in the same industry?
Both are in the Health Care sector, but in different industries: Biotechnology: Electromedical & Electrotherapeutic Apparatus for Electromed and Medical/Dental Instruments for Treace Medical Concepts.